Live
FierceBiotechNIH grant cuts hit women, early-career scientists the hardest: analysisFierceBiotechMRI providers keep eye on rising helium prices amid war in IranEndpoints NewsNovartis to invest $480M in China following AstraZeneca and Lilly pledgesEndpoints NewsFDA posts photos of Indian drugmaking facility cited in warning letterIlluminaIllumina : CSR Report (2025 illumina france gender pay gap english) - marketscreener.comRoche MediaMinistry of Health and Population and Roche Diagnostics sign MoU to advance digital pathology in Egypt - Intelligent CIOBioPharma DiveApogee strengthens case for longer-lasting eczema drugBioPharma DivePfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study resultsAgilentAgilent, Axion Nix Patent Trial, Pause Cases as They Near Deal - Bloomberg Law NewsFierceBiotechApogee eczema data drive hype to new peak as threat to Lilly and Sanofi becomes clearFierceBiotechSanofi returns to T-cell engager territory with $1.2B pact for phase 1-stage trispecificFierceBiotechFDA solicits feedback on controversial national priority voucher review pathway
BioPharma Dive Mar 23, 2026

Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results

Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results

Original
Body unavailable. Use the original source.

Directory

59 All